BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 21, 2027; 33(3): 123673
Published online Jan 21, 2027. doi: 10.3748/wjg.123673
Figure 3
Figure 3 METTL1 regulates PKM2 expression by targeting N7-methylguanosine modification of PKM mRNA. A: Western blot verification of METTL1 knockdown efficiency in PANC-1 cells; B: Distribution characteristics and sequence conservation of N7-methylguanosine (m7G) modification peaks on PKM mRNA before and after METTL1 knockdown via m7G-methylated RNA immunoprecipitation (MeRIP)-sequencing; C: MeRIP-quantitative polymerase chain reaction quantification of m7G modification enrichment of PKM mRNA upon METTL1 overexpression; D and E: Fluorescence imaging and biotin-labeled probe pull-down assay verifying direct binding between METTL1 and PKM mRNA; F: Changes of m7G level and PKM2 expression after METTL1 intervention detected by Dot blot and western blot; G: Western blot analysis of epithelial-mesenchymal transition biomarker expression regulated by METTL1-PKM2 axis. bP < 0.01. m7G: N7-methylguanosine; PCR: Polymerase chain reaction; IgG: Immunoglobulin G.


Write to the Help Desk